Morgan Stanley 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-10 4:36 pm Sale |
2021-08-31 | 13G | Evofem Biosciences, Inc. EVFM |
MORGAN STANLEY MS |
105 0.100% |
-3,965 (-97.42%) |
Filing |
| 2021-06-04 4:29 pm Purchase |
2021-05-25 | 13G | Evofem Biosciences, Inc. EVFM |
MORGAN STANLEY MS |
4,070 5.100% |
4,070 (New Position) |
Filing |